Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants.

about

Overexpression of PY1289-HER3 in sporadic pulmonary carcinoid from patients bearing MEN1 gene variants.

Item

http://www.wikidata.org/entity/Q42721868

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Overexpression of PY1289-HER3 ...... ts bearing MEN1 gene variants.

@en

Overexpression of PY1289-HER3 ...... ts bearing MEN1 gene variants.

@nl

type

Item

label

Overexpression of PY1289-HER3 ...... ts bearing MEN1 gene variants.

@en

Overexpression of PY1289-HER3 ...... ts bearing MEN1 gene variants.

@nl

prefLabel

Overexpression of PY1289-HER3 ...... ts bearing MEN1 gene variants.

@en

Overexpression of PY1289-HER3 ...... ts bearing MEN1 gene variants.

@nl

P1476

Overexpression of PY1289-HER3 ...... nts bearing MEN1 gene variants

@en

P2093

Fabiana Fantini

http://www.w3.org/2001/XMLSchema#string

Gitana Maria Aceto

http://www.w3.org/2001/XMLSchema#string

Maria Cristina Curia

http://www.w3.org/2001/XMLSchema#string

Mauro Piantelli

http://www.w3.org/2001/XMLSchema#string

Pasquale Battista

http://www.w3.org/2001/XMLSchema#string

Serena Veschi

http://www.w3.org/2001/XMLSchema#string

Stefano Iacobelli

http://www.w3.org/2001/XMLSchema#string

P2860

Cell signaling by receptor tyrosine kinases

The ErbB/HER family of protein-tyrosine kinases and cancer

Carboplatin in the treatment of metastatic carcinoid tumours and paraganglioma: a phase II study.

A phase II trial of carboplatin in patients with advanced APUD tumors.

Typical and atypical pulmonary carcinoids : outcome in patients presenting with regional lymph node involvement.

The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics.

ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors.

Systemic therapy, clinical outcomes, and overall survival in locally advanced or metastatic pulmonary carcinoid: a brief report.

Deletions of 11q22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome.

Genetics of neuroendocrine and carcinoid tumours.

P304

453-458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4651

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27347164

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

4906803

http://www.w3.org/2001/XMLSchema#string